Cited by 85Photodynamic Therapy Research StudiesNanoplatforms for cancer theranosticsGlioma Diagnosis and Treatment

Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model

Angell-Petersen, Even, Spetalen, Signe, Madsen, Steen J., Sun, Chung-Ho, Peng, Qian, Carper, Stephen W., Sioud, Mouldy, Hirschberg, Henry·2006·Journal of Neurosurgery

Abstract

Object: Failure of treatment for high-grade gliomas is usually due to local recurrence at the site of resection, indicating that a more aggressive local therapy could be beneficial. Photodynamic therapy (PDT) is a local treatment involving the administration of a tumor-localizing photosensitizing drug, in this case aminolevulinic acid (ALA). The effect depends on the total light energy delivered to the target tissue, but may also be influenced by the rate of light delivery. Methods: In vitro experiments showed that the sensitivity to ALA PDT of BT 4 C multicellular tumor spheroids depended on the rate of light delivery (fluence rate). The BT 4 C tumors were established intracranially in BD-IX rats. Microfluorometry of frozen tissue sections showed that photosensitization is produced with better than 200:1 tumor/normal tissue selectivity after ALA injection. Four hours after intraperitoneal ALA injection (125 mg/kg), 26 J of 632 nm light was delivered interstitially over 15 (high fluence rate) or 90 (low fluence rate) minutes. Histological examination of animals treated 14 days after tumor induction demonstrated extensive tumor necrosis after low-fluence-rate PDT, but hardly any necrosis after high-fluence-rate treatment. Neutrophil infiltration in tumor tissue was increased by PDT, but was similar for both treatment regimens. Low-fluence-rate PDT administered 9 days after tumor induction resulted in statistically significant prolongation of survival for treated rats compared with nontreated control animals. Conclusions: Treatment with ALA PDT induced pronounced necrosis in tumors only if the light was delivered at a low rate. The treatment prolonged the survival for tumor-bearing animals.

Integrity signals

Registry

Crossref · 10.3171/jns.2006.104.1.109

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prolonged animal survival followed by photodynamic therapy using ALA was reported by several groups in various experimental models.

    “Prolonged animal survival followed by photodynamic therapy using ALA was reported by several groups in various experimental models.”

The citation lists haven’t been fetched yet

References 45 · Cited by 85

Authors
Angell-Petersen, E., Spetalen, S., Madsen, S. J., Sun, C.-H., Peng, Q., Carper, S. W., Sioud, M., & Hirschberg, H.
Affiliations
  • Departments of Surgical Oncology, Radiation Biology, Pathology, and Immunology, The Norwegian Radium Hospital, Oslo, Norway; Department of Pathology, Ullevaal University Hospital, Oslo, Norway; Department of Health Physics, University of Nevada Las Vegas Cancer Research Center, and Department of Chemistry, University of Nevada, Las Vegas, Nevada; Department of Neurosurgery, Rikshospitalet, Oslo, Norway; and Beckman Laser Institute, University of California, Irvine, California
  • University of Nevada, Las Vegas (US)
Venue
Journal of Neurosurgery
Published
2006-01
Volume
104
Issue
1
Pages
109-117
ISSN
0022-3085 (ISSN-L)
OpenAlex
W1987265828
Cited by
85
References
45
Citations by year
2025: 4 · 2024: 5 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 8 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 4 · 2013: 1 · 2012: 6
FWCI
5.91
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of neurosurgery (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Universitetet i Bergen
  • National Cancer Institute (CA 62203, P30CA062203)
  • National Center for Research Resources (RR 01192, P41RR001192)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
Keywords
photodynamic therapy, light fluence rate, 5-aminolevulinic acid, high-grade glioma, tumor necrosis, neutrophil infiltration, survival prolongation, photosensitizers, local recurrence
MeSH terms
Aminolevulinic Acid, Animals, Brain Neoplasms, Disease Models, Animal, Glioma, Light, Necrosis, Photochemotherapy, Survival Analysis, Photosensitizing Agents, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review